Present and future of metastatic colorectal cancer treatment: A review of new candidate targets

In the last two decades, great efforts have been made in the treatment of metastatic colorectal cancer (mCRC) due to the approval of new target agents for cytotoxic drugs. Unfortunately, a large percentage of patients present with metastasis at the time of diagnosis or relapse after a few months. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Giulia, Troiani, Teresa, Cardone, Claudia, Vitiello, Pietropaolo, Sforza, Vincenzo, Ciardiello, Davide, Napolitano, Stefania, Della Corte, Carminia Maria, Morgillo, Floriana, Raucci, Antonio, Cuomo, Antonio, Selvaggi, Francesco, Ciardiello, Fortunato, Martinelli, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514633/
https://www.ncbi.nlm.nih.gov/pubmed/28765689
http://dx.doi.org/10.3748/wjg.v23.i26.4675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514633/
https://www.ncbi.nlm.nih.gov/pubmed/28765689
http://dx.doi.org/10.3748/wjg.v23.i26.4675

Ejemplares similares